Oxford Nanopore at AMP 2026
Overview
The Association for Molecular Pathology (AMP) Annual Meeting & Expo features more than 200 exhibiting companies, 60 educational sessions, nearly 400 poster presentations, and 3,000+ attendees/exhibitors.
Oxford Nanopore will be located at Booth 604, and will host 2 Corporate Workshops on Wednesday, November 11.
Exhibits will be open from November 12 to November 14.
Oncology Workshop
Oxford Nanopore Technologies: Revolutionizing oncology with comprehensive multiomic sequencing solutions
Join Oxford Nanopore Technologies to explore how real-time, direct DNA sequencing is transforming oncology research and clinical applications. The session will feature two pioneering applications of nanopore technology in oncology. Dr. Francisco Marchi will present the Acute Leukemia Methylome Atlas, built from over 3,000 leukemia samples, demonstrating how long read nanopore sequencing and machine learning can predict AML subtypes and patient outcomes with remarkable accuracy. Dr. Areeba Patel will discuss rapid, comprehensive molecular profiling of CNS tumors using methylation-based nanopore sequencing, showcasing its potential for clinical implementation. Together, these talks highlight how nanopore sequencing is redefining precision oncology with speed, flexibility, and multiomic depth.
Date: Wednesday, November 12, 2025
Time: 12:00 pm-12:50 pm EST
Location: Room 155, Level 1, Boston Convention and Exhibition Center
Rare Disease Workshop
Enabling more complete rare disease analysis with long-read sequencing
Rare disease research requires the detection of complex genomic variation that can be challenging to capture using traditional short-read sequencing approaches alone. This workshop will provide an overview of how long-read sequencing technologies are expanding genomic analysis through more comprehensive characterization of structural variants, repeat expansions, and other difficult-to-resolve genomic features. Through case studies and practical examples, attendees will explore how long-read sequencing can uncover biologically relevant variation missed by conventional methods, improving the resolution of challenging genomic regions, and broadening the scope of rare disease studies.
Date: Wednesday, November 11, 2026
Time: 01:00 pm-01:50 pm PST
Location: Tahoma 4, Level 3, Arch at 800 Pike
)